Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunil Healthcare Ltd has scheduled its 266th Board Meeting on Friday, February 6, 2026, to consider and approve the unaudited financial results (both standalone and consolidated) for the third quarter and nine months ended December 31, 2025 (FY 2025-26). The results will be sent for limited review by the company's statutory auditors before final approval. The meeting will be conducted through video conferencing, with the registered office in New Delhi as the deemed venue. The company has also confirmed that the insider trading window remains closed from January 1, 2026 to February 8, 2026, in line with SEBI insider trading norms. The intimation has been filed under SEBI LODR Regulations 29 read with 33.
This is a routine pre-results announcement, and investors should expect the Q3 FY26 earnings to be declared around February 6-8, 2026. The trading window closure means company insiders cannot trade in the stock during this period, which is standard practice ahead of results and is neutral for retail investors.